Table 13.
Univariate and multi-variate models assessing the impact of the COVID-19 pandemic on HIV testing rates among people hospitalised for an injecting-related hospital admission (IRHA) in rest of Glasgow, 2010–2021 (June 2021 only)
| Co-variates | N | HIV test in the last year (% of N) | Univariateb | Multi-variateb | ||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | aOR (95% CI) | P value | |||
| Time perioda | ||||||
| Pre-outbreak (2010–2014) | 1,770 | 180 (10%) | 0.24 (0.20–0.29) | < 0.001 | 0.21 (0.17–0.25) | < 0.001 |
| Early outbreak (2015–2016) | 1,198 | 275 (23%) | 0.64 (0.55–0.76) | < 0.001 | 0.57 (0.48–0.68) | < 0.001 |
| Ongoing outbreak (2017–2019) | 1,823 | 577 (32%) | 1 | 1 | ||
| COVID-19 (2020–2021) | 926 | 356 (38%) | 1.35 (1.15–1.57) | < 0.001 | 1.40 (1.19–1.66) | < 0.001 |
| Gender | ||||||
| Male | 3,037 | 813 (27%) | 1 | 1 | ||
| Female | 1,401 | 348 (25%) | 0.87 (0.76–1.01) | 0.061 | 0.80 (0.69–0.93) | 0.004 |
| Age groupa | ||||||
| < 35 | 2,328 | 430 (18%) | 1 | 1 | ||
| 35–45 | 1,860 | 578 (31%) | 1.99 (0.71–2.31) | < 0.001 | 1.05 (0.88–1.24) | 0.599 |
| 46 + | 1,529 | 380 (25%) | 1.45 (1.23–1.73) | < 0.001 | 0.85 (0.71–2.02) | 0.087 |
| Methadone prescribinga | ||||||
| Not prescribed | 2,867 | 353 (12%) | 1 | 1 | ||
| In the last 6 months | 2,369 | 863 (36%) | 4.08 (3.53–2.47) | < 0.001 | 4.69 (3.97–5.55) | < 0.001 |
| In the past but not the last 6 months | 481 | 172 (36%) | 3.96 (3.18–4.93) | < 0.001 | 4.16 (3.27–5.31) | < 0.001 |
OR odds ratio, aOR adjusted odds ratio
aTime varying co-variate; people can be included in multiple categories
bMulti-level framework to adjust for across time period duplicates